1,076 institutions hold shares in HCA Healthcare Inc. (HCA), with 73.75M shares held by insiders accounting for 21.70% while institutional investors hold 91.00% of the company’s shares. The shares outstanding are 338.17M, and float is at 264.82M with Short Float at 0.92%. Institutions hold 71.26% of the Float.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The top institutional shareholder in the company is Price (T.Rowe) Associates Inc with over 25.16 million shares valued at $4.14 billion. The investor’s holdings represent 7.44% of the HCA Shares outstanding. As of Dec 30, 2020, the second largest holder is Vanguard Group, Inc. (The) with 20.79 million shares valued at $3.42 billion to account for 6.14% of the shares outstanding. The other top investors are Blackrock Inc. which holds 18.25 million shares representing 5.39% and valued at over $3.0 billion, while Wellington Management Company, LLP holds 5.22% of the shares totaling 17.66 million with a market value of $2.9 billion.
HCA Healthcare Inc. (NYSE: HCA) is 6.45% higher on its value in year-to-date trading and has touched a low of $58.38 and a high of $181.01 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HCA stock was last observed hovering at around $174.82 in the last trading session, with the day’s gains setting it 0.25% off its average median price target of $195.00 for the next 12 months. It is also 17.81% off the consensus price target high of $213.00 offered by 23 analysts, but current levels are -16.71% lower than the price target low of $150.00 for the same period.
Currently trading at $175.07, the stock is 1.98% and 4.20% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.35 million and changing 0.14% at the moment leaves the stock 29.54% off its SMA200. HCA registered 25.03% gain for a year compared to 6-month gain of 32.12%. The firm has a 50-day simple moving average (SMA 50) of $170.74 and a 200-day simple moving average (SMA200) of $148.25.
The stock witnessed a 4.85% loss in the last 1 month and extending the period to 3 months gives it a 16.06%, and is 0.61% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.30% over the week and 2.93% over the month.
HCA Healthcare Inc. (HCA) has around 210000 employees, a market worth around $58.32B and $51.53B in sales. Current P/E ratio is 16.03 and Fwd P/E is 12.34. Profit margin for the company is 6.50%. Distance from 52-week low is 199.88% and -3.28% from its 52-week high. The company has generated returns on investments over the last 12 months (19.10%).
HCA Healthcare Inc. (HCA) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for HCA Healthcare Inc. (HCA) is a “Overweight”. 23 analysts offering their recommendations for the stock have an average rating of 1.90, where 4 rate it as a Hold and 1 think it is a “Overweight”. 17 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
HCA Healthcare Inc. is expected to release its quarterly report on 05/04/2021 and quarterly earnings per share for the current quarter are estimated at $3.3 with sales reaching $13.58B over the same period.The EPS is expected to grow by 10.50% this year, but quarterly earnings will post 5.90% year-over-year. Quarterly sales are estimated to grow 5.60% in year-over-year returns.
HCA Healthcare Inc. (HCA) Insider Activity
A total of 120 insider transactions have happened at HCA Healthcare Inc. (HCA) in the last six months, with sales accounting for 72 and purchases happening 48 times. The most recent transaction is an insider sale by Wyatt Christopher F., the company’s SVP & Controller. SEC filings show that Wyatt Christopher F. sold 3,200 shares of the company’s common stock on Feb 19 at a price of $177.06 per share for a total of $0.57 million. Following the sale, the insider now owns 28180.0 shares.
HCA Healthcare Inc. disclosed in a document filed with the SEC on Feb 19 that Berres Jennifer (SVP & Chief Human Res. Officer) sold a total of 6,692 shares of the company’s common stock. The trade occurred on Feb 19 and was made at $176.05 per share for $1.18 million. Following the transaction, the insider now directly holds 3380.0 shares of the HCA stock.
Still, SEC filings show that on Feb 08, Foster Jon M (Group President) disposed off 6,171 shares at an average price of $176.44 for $1.09 million. The insider now directly holds 0 shares of HCA Healthcare Inc. (HCA).
HCA Healthcare Inc. (HCA): Who are the competitors?
The company’s main competitors (and peers) include Community Health Systems Inc. (CYH) that is trading 42.52% up over the past 12 months. Universal Health Services Inc. (UHS) is -5.27% down on the 1-year trading charts. Short interest in the company’s stock has fallen -54.69% from the last report on Dec 30, 2020 to stand at a total of 3.79 million short shares sold with a short interest ratio of 1.83.